CytomX Therapeutics: Q1 Earnings Insights

CytomX Therapeutics CTMX reported its Q1 earnings results on Thursday, May 5, 2022 at 04:15 PM.

Here's what investors need to know about the announcement.

Earnings

CytomX Therapeutics missed estimated earnings by 2.78%, reporting an EPS of $-0.37 versus an estimate of $-0.36.

Revenue was up $1.17 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.12 which was followed by a 14.12% increase in the share price the next day.

Here's a look at CytomX Therapeutics's past performance:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.28 -0.31 -0.32 -0.35
EPS Actual -0.40 -0.35 -0.30 -0.26
Revenue Estimate 24.51M 18.08M 16.86M 15.43M
Revenue Actual 19.73M 17.59M 16.29M 15.97M

To track all earnings releases for CytomX Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!